Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-controlled Study to Evaluate the Effect of Tocilizumab on Disease Response in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA), With an Open-label Extension to Examine the Long Term Use of Tocilizumab
Conditions
Interventions
tocilizumab [RoActemra/Actemra]
Placebo
+3 more
Locations
54
United States
Little Rock, Arkansas, United States
Los Angeles, California, United States
Hartford, Connecticut, United States
Augusta, Georgia, United States
Chicago, Illinois, United States
Louisville, Kentucky, United States
Start Date
May 1, 2008
Primary Completion Date
September 1, 2009
Completion Date
August 1, 2014
Last Updated
July 25, 2016
NCT06870045
NCT04902807
NCT04833465
NCT07000916
NCT06007456
NCT05572424
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions